AnticoagEvaluator 17+

American College of Cardiology

Designed for iPad

    • Free

Screenshots

Description

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

What’s New

Version 4.3

This app has been updated in accordance with the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation to incorporate additional stroke risk models (ATRIA, GARFIELD), a mortality risk model (GARFIELD), and updates to the existing stroke and bleed risk calculations. This update also includes updated therapy guidance and renal-adjusted therapy dosing information.

App Privacy

The developer, American College of Cardiology, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.

Data Not Linked to You

The following data may be collected but it is not linked to your identity:

  • Usage Data

Privacy practices may vary based on, for example, the features you use or your age. Learn More

More By This Developer

ACC Guideline Clinical App
Medical
ASCVD Risk Estimator Plus
Medical
Heart Songs
Medical
NCD Academy
Education
Statin Intolerance
Medical
ACC.24
Reference

You Might Also Like

MAQI2 Anticoagulation Toolkit
Medical
Anticoagulation Manager
Medical
Mayo Clinic Cardiovascular CME
Medical
Cardiac Trials
Medical
SCAI Point-of-Care App
Medical
Preop Eval
Medical